We are live on ! Find out more
LIM

Lagoda Investment Management Portfolio holdings

AUM $162M
1-Year Est. Return 49.7%
This Fund
S&P 500
This Quarter Est. Return
+17.82%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$333M
AUM Growth
+$64.3M
Cap. Flow
+$25.4M
Cap. Flow %
7.64%
Top 10 Hldgs %
70.78%
Holding
29
New
1
Increased
14
Reduced
8
Closed

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$10.4M
2
UI icon
Ubiquiti
UI
+$5.96M
3
VNRX icon
VolitionRx Ltd
VNRX
+$5.07M
4
TTOO
T2 Biosystems, Inc
TTOO
+$3.02M
5
DMRC icon
Digimarc Corp
DMRC
+$1.76M

Sector Composition

Rank Sector Weight
1 Healthcare 48.15%
2 Technology 20.9%
3 Communication Services 12.14%
4 Financials 9.29%
5 Materials 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
1
DELISTED
Seagen Inc. Common Stock
SGEN
$30.6M 9.21%
567,057
+1,814
+0.3% +$86K
REGN icon
2
Regeneron Pharmaceuticals
REGN
$78.5B
$29.4M 8.84%
73,131
+393
+0.5% +$158K
RNR icon
3
RenaissanceRe
RNR
$13.3B
$25.1M 7.54%
208,602
+28
+0% +$3.3K
DMRC icon
4
Digimarc Corp
DMRC
$147M
$25M 7.52%
651,878
+49,428
+8% +$1.76M
PTC icon
5
PTC
PTC
$15.8B
$22.5M 6.78%
508,763
+13,370
+3% +$554K
UI icon
6
Ubiquiti
UI
$33.7B
$22M 6.6%
410,421
+124,284
+43% +$5.96M
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.36T
$21.7M 6.52%
557,400
+9,520
+2% +$361K
SNMX
8
DELISTED
Senomyx, Inc.
SNMX
$20.7M 6.21%
4,849,662
+397,234
+9% +$1.44M
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
$19.3M 5.82%
157,853
+293
+0.2% +$37.7K
NVO
10
Novo Nordisk
NVO
$208B
$19.1M 5.75%
919,084
-61,012
-6% -$1.51M
MON
11
DELISTED
Monsanto Co
MON
$17.9M 5.38%
175,123
+98,925
+130% +$10.4M
VNRX icon
12
VolitionRx Ltd
VNRX
$8.65M
$15.5M 4.67%
146,375
+65,311
+81% +$5.07M
TTOO
13
DELISTED
T2 Biosystems, Inc
TTOO
$13.6M 4.1%
376
+92
+32% +$3.02M
PGEN icon
14
Precigen
PGEN
$2.24B
$13.5M 4.05%
484,529
+10,376
+2% +$274K
MACK
15
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$11.9M 3.57%
237,776
-47,447
-17% -$1.97M
BIDU icon
16
Baidu
BIDU
$37.7B
$9.76M 2.93%
53,579
+4,574
+9% +$791K
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.36T
$8.96M 2.69%
222,820
-1,800
-0.8% -$70.4K
ESGR
18
DELISTED
Enstar Group
ESGR
$3.21M 0.97%
19,528
-2,382
-11% -$392K
MA icon
19
Mastercard
MA
$502B
$1.82M 0.55%
17,935
-3,443
-16% -$330K
BRK.A icon
20
Berkshire Hathaway Class A
BRK.A
$1.1T
$432K 0.13%
2
-2
-50% -$439K
BRK.B icon
21
Berkshire Hathaway Class B
BRK.B
$1.1T
$202K 0.06%
+1,400
New +$205K
Y
22
DELISTED
Alleghany Corp
Y
$142K 0.04%
270
XOM icon
23
ExxonMobil
XOM
$644B
$62K 0.02%
715
COP icon
24
ConocoPhillips
COP
$147B
$54K 0.02%
1,231
-119
-9% -$4.94K
PFE icon
25
Pfizer
PFE
$143B
$50K 0.02%
1,557
-63
-4% -$2.11K

Similar funds

Lagoda Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Lagoda Investment Management held 29 positions worth $333M, up 24% from $268M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Lagoda Investment Management deployed $25.4M of net new capital in Q3 2016, opening 1 new position and adding to 14 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 1,400 shares worth $202K.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Merrimack Pharmaceuticals, Inc., an estimated $1.97M trimmed.

  • Lagoda Investment Management's largest Q3 2016 buy was Berkshire Hathaway Class B: 1,400 shares worth $202K.
  • Lagoda Investment Management added most to Monsanto Co in Q3 2016, an estimated $10.4M increase.
  • Lagoda Investment Management's biggest Q3 2016 reduction was Merrimack Pharmaceuticals, Inc., cutting an estimated $1.97M.
  • Lagoda Investment Management's ten largest holdings make up 71% of its $333M portfolio in Q3 2016.
  • Lagoda Investment Management opened 1 new position and closed 0 in Q3 2016.
  • Lagoda Investment Management's portfolio value rose 24% quarter-over-quarter to $333M.

Based on Lagoda Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.